Morphine Market Regional Analysis:
North America Market Insights
North America morphine market is projected to account for revenue share of more than 35% by the end of 2035. This can be ascribed to the increasing patient pool of osteoporosis. U.S. Food and Drug Administration in 2024 stated that in the U.S., osteoporosis affects 1 in 4 women aged 65 or older. Moreover, a high share of the geriatric population in countries, such as the United States and Canada, is estimated to propel the regional morphine market growth. For instance, data published by the government of Canada in 2022, currently 2.3% of the population in the country is aged 85 and older.
Asia Pacific Market Insights
By the end of 2035, Asia Pacific morphine market is expected to hold over 28% revenue share. The increasing investment in the healthcare sector and rising awareness about palliative care medication in the region are major growth-propelling factors. Countries such as India, and China have well-developed healthcare infrastructures with proper pain management medications such as morphine use. For instance, in January 2025, an article published by DD News in India stated that the healthcare market is projected to reach USD 5 trillion by 2030. The burgeoning health industry is leading to increased demand and widespread availability of effective pain suppressants such as morphine.
